Deal Build-Up Amid Early ‘Deep’ Response For IGI’s Trispecific In Myeloma

 
• By Anju Ghangurde
  
multiple myeloma
Deal Chatter For IGI's early-stage MM asset (Shutterstock)

More from ASCO

More from Focus On Asia